Strides Pharma Science Ltd (SRID)

Currency in INR
823.15
-15.10(-1.80%)
Closed·
SRID Scorecard
Full Analysis
High shareholder yield
SRID is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
817.60847.55
52 wk Range
454.93972.00
Key Statistics
Bid/Ask
823.00 / 821.80
Prev. Close
838.25
Open
838.25
Day's Range
817.6-847.55
52 wk Range
454.93-972
Volume
206.06K
Average Volume (3m)
659.07K
1-Year Change
77.18%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SRID Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1,078.50
Upside
+31.02%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 3 consecutive years

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Strides Pharma Science Ltd Company Profile

Strides Pharma Science Limited develops and manufactures pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. The company operates through one segment: Pharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women’s health, CNS, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. In addition, the company offers market and trade in pharmaceutical and ancillary products. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.

Employees
3301
Market
India

Compare SRID to Peers and Sector

Metrics to compare
SRID
Peers
Sector
Relationship
P/E Ratio
22.6x27.8x−0.5x
PEG Ratio
0.000.830.00
Price/Book
3.0x4.5x2.6x
Price / LTM Sales
1.7x4.4x3.3x
Upside (Analyst Target)
28.7%12.3%43.5%
Fair Value Upside
Unlock6.8%6.3%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 1,078.50
(+31.02% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 37.10%
Dividend Yield
0.48%
Industry Median 0.72%
Annualised payout
4.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jul 29, 2025
EPS / Forecast
10.80 / --
Revenue / Forecast
11.20B / --
EPS Revisions
Last 90 days

SRID Income Statement

People Also Watch

1,704.60
COFO
-2.40%
2,049.00
GLEN
-1.25%
2,368.90
BSEL
-4.73%
933.00
NATP
-0.18%
386.60
BAJE
-0.76%

FAQ

What Stock Exchange Does Strides Pharma Trade On?

Strides Pharma is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Strides Pharma?

The stock symbol for Strides Pharma is "SRID."

What Is the Strides Pharma Market Cap?

As of today, Strides Pharma market cap is 75.54B.

What Is Strides Pharma's Earnings Per Share (TTM)?

The Strides Pharma EPS (TTM) is 37.10.

When Is the Next Strides Pharma Earnings Date?

Strides Pharma will release its next earnings report on 23 Oct 2025.

From a Technical Analysis Perspective, Is SRID a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Strides Pharma Stock Split?

Strides Pharma has split 0 times.

How Many Employees Does Strides Pharma Have?

Strides Pharma has 3301 employees.

What is the current trading status of Strides Pharma (SRID)?

As of 05 Aug 2025, Strides Pharma (SRID) is trading at a price of 823.15, with a previous close of 838.25. The stock has fluctuated within a day range of 817.60 to 847.55, while its 52-week range spans from 454.93 to 972.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.